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Synopsis		
Mycobacterium	tuberculosis,	 the	etiological	 agent	of	 tuberculosis,	 has	adapted	with	the	 host	 environment	 and	 evolved	 to	 survive	 in	 harsh	 conditions	 in	 the	 host.	 The	pathogen	 has	 successfully	 evolved	 strategies	 not	 only	 to	 evade	 the	 host	 immune	system	but	also	to	thrive	within	the	host	cells.	Upon	infection,	the	pathogen	is	either	cleared	 due	 to	 the	 host	 immune	 response,	 or	 it	 survives	 and	 causes	 active	tuberculosis	(TB)	 infection.	 In	a	number	of	cases	however,	 the	pathogen	 is	neither	killed	nor	does	 it	 actively	proliferate,	but	 it	 remains	dormant	 in	 the	host	until	 the	environment	becomes	favorable.	This	dormant	state	of	pathogen	is	responsible	for	latent	 TB	 infection	 (LTBI).	WHO	 reports	 indicated	 that	 as	much	 as	 a	 third	 of	 the	whole	 world’s	 population	 is	 exposed	 to	 the	 pathogen,	 of	 which	 a	 significant	proportion	could	be	latently	infected	(WHO	report,	2015).	These	individuals	do	not	show	symptoms	of	active	TB	infection	and	hence	are	difficult	to	detect.	The	latent	TB	infected	(LTBI)	individuals	serve	as	a	reservoir	for	the	pathogen,	which	can	lead	to	epidemics	 when	 the	 conditions	 change.	 Hence,	 it	 is	 necessary	 to	 understand	 the	host-pathogen	 interactions	during	LTBI,	 as	 this	might	 provide	 clues	 to	 developing	new	strategies	to	detect	and	curb	a	latent	infection.		Host-pathogen	 interactions	 are	 multifaceted,	 in	 which	 both	 species	 attempt	 to	recognize	and	respond	to	each	other,	all	of	these	through	specific	molecules	making	distinct	 interactions	with	 the	 other	 species.	 	 The	 outcome	 of	 the	 infection	 is	 thus	decided	by	a	complex	set	of	host-pathogen	interactions.	The	complexity	arises	since	a	 large	 number	 of	 molecular	 components	 are	 involved,	 also	 multiplicity	 of	interactions	among	these	components	and	due	to	several	feedback,	feed	forwards	or	other	regulatory	or	influential	loops	within	the	system.		The	complexity	of	biological	systems	makes	modeling	and	 simulation	an	essential	 and	 critical	part	of	 systems–level	 studies.	Systems	biology	studies	provide	an	 integrated	 framework	 to	analyze	and	understand	the	function	of	biological	systems.			This	work	addresses	some	of	 these	 issues	with	an	unbiased	systems-level	analysis	so	as	to	identify	and	understand	the	important	global	changes	both	in	the	host	and	in	the	pathogen	during	LTBI.	 	The	broad	objectives	of	the	work	was	to	identify	the	
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key	 processes	 that	 vary	 in	 the	 host	 during	 latent	 infection,	 the	 set	 of	 metabolic	reactions	in	the	host	which	can	be	modulated	to	control	the	reactivation	of	infection,	global	 adaptation	 in	 Mycobacterium	 tuberculosis	 (Mtb)	 and	 then	 to	 utilize	 this	knowledge	to	 identify	strategies	 for	tackling	 latent	 infection.	A	review	of	 literature	of	the	current	understanding	of	latency	from	the	pathogen	and	the	host	perspective	is	 described	 in	 chapter	 1.	 From	 this,	 it	 is	 clear	 that	 most	 available	 studies	 have	focused	on	the	role	of	individual	molecules	and	individual	biological	processes	such	as	 granuloma	 formation,	 toll-like	 receptor	 signaling,	 T	 cell	 responses	 as	 well	 as	cytokine	signaling,	in	either	initiating	or	maintaining	a	latent	infection,	but	there	is	no	report	till	date	about	whether	and	how	these	processes	are	connected	with	each	other.	 While	 transcriptome	 based	 studies	 have	 identified	 lists	 of	 differentially	expressed	genes	in	LTBI	as	compared	to	healthy	controls,	no	further	understanding	is	 currently	 available	 for	 many	 of	 them,	 regarding	 the	 processes	 they	 may	 be	involved	 in	 and	 what	 interactions	 they	 make,	 which	 may	 be	 important	 for	understanding	LTBI.		The	 first	 part	 of	 the	 work	 is	 a	 systematic	 meta-analysis	 of	 genome-scale	 protein	interaction	 networks	 rendered	 condition-specific	 with	 transcriptome	 data	 of	patients	 with	 LTBI,	 which	 has	 provided	 a	 global	 unbiased	 picture	 of	 the	transcriptional	and	metabolic	variations	in	the	host	and	in	the	pathogen	during	the	latent	 infection.	 	 To	 start	 with,	 publicly	 available	 gene	 expression	 data	 related	 to	LTBI,	active	TB	and	healthy	controls	were	considered.		In	all,	183	datasets	summing	up	 to	 105	 LTBI,	 41	 active	 TB	 and	 37	 healthy	 control	 samples	 were	 analyzed.	(Chapter	 2).	 	 Standard	 analysis	 of	 the	 transcriptome	 profiles	 of	 these	 datasets	indicated	 that	 there	was	zero	overlap	among	 them	and	 that	not	a	 single	gene	was	seen	 in	 common	 among	 all	 datasets	 for	 the	 same	 condition.	 	 An	 extensive	 human	protein-protein	 interaction	 network	 was	 constructed	 using	 information	 available	from	 multiple	 resources	 that	 comprehensively	 contained	 structural	 or	 physical	interactions	and	genetic	interactions	or	functional	influences.	Nodes	in	this	network	represented	 individual	proteins	and	edges	 represented	 interactions	between	pairs	of	nodes.	The	identity	of	each	node	and	the	nature	of	interaction	of	each	edge	along	with	 the	 type	 of	 evidence	 that	 was	 used	 as	 the	 basis	 for	 drawing	 the	 edge,	 was	collated	 for	 the	network.	The	gene	expression	data	was	 integrated	 into	 the	human	
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protein-protein	interaction	(PPI)	network	for	each	condition,	which	essentially	had	weighted	nodes	and	directed	edges,	 specific	 to	 that	 condition,	 from	which	 specific	comparative	networks	were	derived.	The	highest	ranked	perturbations	in	LTBI	were	identified	 through	 a	 network	 mining	 protocol	 previously	 established	 in	 the	laboratory.	 	 This	 involved	 computing	 all	 versus	 all	 shortest	 paths	 on	 the	comparative	 network,	 scoring	 the	 paths	 based	 on	 connectedness	 and	 various	centrality	measures	of	the	nodes	and	the	edges	and	finally	ranking	the	paths	based	on	 the	 cumulative	 path	 scores.	 Intriguingly,	 the	 top-ranked	 set	 of	 perturbations	were	 found	 to	 form	 a	 connected	 sub-network	 by	 themselves,	 referred	 to	 as	 a	 top	perturbed	 sub-network	 (top-net),	 indicating	 that	 they	were	 functionally	 linked	 or	perhaps	even	orchestrated	 in	some	sense.	Th17	signaling	appears	 to	be	dominant.	About	40	genes	were	identified	in	the	unique	set	of	LTBI	condition	as	compared	to	the	active	TB	condition,	and	these	genes	showed	enrichment	for	processes	such	as	apoptosis,	cell	cycle	as	well	as	natural	killer	cell	mediated	toxicity.	Construction	and	analysis	 of	 a	 miRNA	 network	 indicated	 that	 32	 of	 these	 have	 strong	 associations	with	miRNA	explaining	the	role	of	the	latter	in	controlling	LTBI.	3	other	genes	from	the	 top-net	are	already	established	drug	 targets	 for	different	diseases	with	known	drugs	 associated	 with	 them,	 which	 are	 BCL2,	 HSP90AA1	 and	 NR3C1.	 These	 3	proteins	can	be	explored	further	as	drug	targets	in	LTBI	whose	manipulation	using	existing	drugs	may	result	in	inhibiting	the	underlying	biological	process	and	thereby	result	in	disturbing	the	state	of	latency.				As	 a	 second	 objective,	 global	 variations	 in	 the	 host	 transcriptome	were	 identified	during	ascorbic	acid	induced	dormancy	(Chapter	3).	Ascorbic	acid	or	Vitamin	C	is	a	nutrient	 supplement	 required	 in	 the	 diet.	 This	 organic	 compound	 has	 a	 known	antioxidant	property,	as	it	is	known	to	scavenge	the	free	radicals.	In	a	recent	study,	Taneja	et	al,	demonstrated	that	Vitamin	C	could	induce	dormancy	in	Mtb.	On	similar	lines,	experiments	were	done	in	THP-1	cells	infected	with	Mtb	to	determine	the	host	responses	 during	 ascorbic	 acid	 (AA)	 induced	 dormancy.	 The	 raw	 gene	 expression	data	was	provided	by	our	collaborator	Prof.	Jaya	Tyagi		that	included	0	hour,	4	days	and	 6	 days	 time	 points	 with	 infection	 and	 vitamin	 C	 versus	 infection	 alone	 or	vitamin	C	alone	as	controls.	The	transcriptome	data	was	normalized	and	integrated	into	 the	 human	 PPI	 network	 as	 described	 for	 the	 meta-analyses.	 It	 was	
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experimentally	 determined	 that	 ascorbic	 acid	 induces	 dormancy	 in	 4	 days	 post	infection.	 The	 top-ranked	 paths	 of	 perturbation	were	 analyzed	 and	 compared	 for	three	 different	 conditions:	 (i)	 uninfected	 condition,	 (ii)	 AA	 treated	 and	 infected	condition,	 and	 (iii)	 AA,	 isoniazid	 and	 infected	 condition.	 The	 dormant	 pathogen	 is	known	to	be	drug-tolerant	and	thus	as	a	marker	for	the	state	of	dormancy,	the	lack	of	 effect	 of	 isoniazid	 is	 also	 monitored	 in	 the	 infected	 host	 cells.	 The	 analysis	revealed	that	there	were	some	broad	similarities	as	compared	to	LTBI	from	patient	samples	but	AA	induced	dormancy	in	cell	lines	stood	out	a	separate	group	indicating	that	 there	 were	 significant	 differences	 such	 as	 involving	 Interferon	 Induced	Transmembrane	 Proteins	 (IFITMs),	 vacuolar	 ATPase	 as	 well	 as	 GDF15,	 which	belongs	 to	 TGF-beta	 signaling	 pathway.	 The	 highest	 ranked	 perturbed	 paths	contained	genes	involved	in	innate	immune	responses	of	which	ISG15,	IFITMs,	HLAs	and	ATPases	emerge	as	the	most	altered	in	the	dormant	condition.	CCR7	emerges	as	a	 key	discriminator,	which	 is	 subdued	 in	 the	 latent	 samples	but	highly	 induced	 in	infection	 conditions.	 Pathway-based	 analysis	 of	 different	 conditions	 showed	 that	oxidative	stress,	glutathione	metabolism,	proteasome	degradation	as	well	as	type	II	interferon	signaling	are	significantly	up-regulated	in	AA	induced	dormancy.		The	dormant	bacteria	reside	 in	 the	host	cells	and	are	known	to	modulate	 the	host	metabolism	 for	 their	 own	 benefit.	 So,	 the	 third	 objective	 was	 to	 understand	 the	metabolic	variations	in	the	host	during	LTBI	(Chapter	4).	A	genome-scale	metabolic	(GSM)	model	of	alveolar	macrophage	was	used	 in	 this	study.	The	metabolic	model	contains	information	of	the	reactions,	metabolites	and	the	genes	encoding	enzymes	that	 catalyze	a	particular	 reaction.	Flux	balance	analysis	 (FBA),	 a	 constraint-based	metabolic	modeling	method,	is	used	for	analyzing	the	alterations	in	the	metabolism	under	different	 infection	conditions.	 In	order	 to	mimic	 the	physiological	condition,	gene	expression	data	was	used	 for	constraining	 the	bounds	of	 the	reactions	 in	 the	model.	 Two	 different	 expression	 studies	were	 used	 for	 analysis:	 GSE25534	 (from	Chapter	 2)	 and	 ascorbic	 acid	 induced	 dormancy	 (Chapter	 3).	 The	 analysis	 was	carried	out	 for	 latent	TB	versus	healthy	 control	 and	 latent	TB	versus	 active	TB	 to	identify	the	most	altered	metabolic	processes	in	LTBI.	Differences	in	fluxes	between	the	 two	 conditions	 were	 calculated.	 A	 new	 classification	 scheme	 was	 devised	 to	categorize	the	reactions	on	the	basis	of	flux	differences.	In	this	chapter,	higher	fluxes	
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in	 LTBI	 condition	 were	 identified	 for	 reactions	 involved	 in	 transport	 of	 small	metabolites	 as	 well	 as	 amino	 acids.	 Solute	 carrier	 proteins	 responsible	 for	 the	transport	 of	 the	 metabolites	 were	 identified	 and	 their	 biological	 significance	 is	discussed.	 Reduced	 glutathione	 (GSH),	 arachidonic	 acid,	 prostaglandins,	pantothenate	were	 identified	as	 important	metabolites	 in	LTBI	condition	and	their	physiological	 role	has	been	described.	Sub-system	analysis	 for	different	conditions	shows	 differential	 regulation	 for	 arachidonic	 acid	 metabolism,	 fatty	 acid	metabolism,	 folate	metabolism,	pyruvate	metabolism,	glutathione	metabolism,	ROS	detoxification,	 triacylglycerol	 synthesis	 and	 transport	 as	 well	 as	 tryptophan	metabolism.	From	the	study,	transporter	proteins	and	reactions	altered	during	LTBI	were	identified,	which	again	provide	clues	for	understanding	the	molecular	basis	of	establishing	a	latent	infection.		
Mycoabcterium	tuberculosis	is	known	to	undergo	dormancy	during	stress	conditions.	In	 this	 chapter,	 the	 main	 objective	 was	 to	 identify	 the	 global	 variations	 in	 the	dormant	 Mtb	 (Chapter	 5).	 To	 carry	 out	 the	 analysis,	 the	 Mtb	 PPI	 network	 was	constructed	 using	 information	 from	 available	 resources.	 Gene	 expression	 data	 of	two	 different	 dormancy	models,	Wayne	 growth	model	 and	multiple-stress	model,	were	 used	 for	 the	 study.	 To	 identify	 the	 key	 players	 involved	 in	 reversal	 of	dormancy,	 the	 transcriptome	 data	 of	 reaeration	 condition	 was	 also	 used.	 In	 this	study,	 the	 Max-flow	 algorithm	was	 implemented	 to	 identify	 the	 feasible	 paths	 or	flows	 in	 different	 condition.	 The	 flows	 with	 higher	 scores	 indicate	 that	 more	information	is	traversed	by	the	path,	and	hence	is	important	for	the	study.	From	the	analysis	 of	 Wayne	 growth	 model	 (hypoxia	 model),	 important	 transcriptional	regulators	such	as	SigB,	SigE,	SigH,	regulators	in	the	two-component	system	such	as	MprA,	 MtrA,	 PhoP,	 RegX3	 and	 TrcR	 were	 identified	 in	 stress	 condition.	 Multiple-stress	 model	 studied	 the	 growth	 of	 bacteria	 in	 low	 oxygen	 concentration,	 high	carbon	dioxide	levels,	low	pH	and	nutrient	starvation.	The	gene	expression	data	was	integrated	 in	 the	 Mtb	 PPI	 network	 and	 implementation	 of	 Max-flow	 algorithm	showed	 that	MprA,	 part	 of	 the	MprA-MprB	 two-component	 system,	 is	 involved	 in	the	regulation	of	persistent	condition.	WhiB1	also	features	in	the	paths	of	dormant	condition	 and	 its	 role	 in	 persistence	 can	be	 explored.	 In	 reaeration	model,	WhiB1	and	WhiB4	are	present	 in	 the	 top	 flows	of	 this	condition	 indicating	 that	 the	redox	
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state	 is	 perturbed	 in	 the	 pathogen	 and	 the	 interactions	 of	 these	 proteins	 are	important	to	understand	the	reversal	of	dormant	condition.	From	the	study,	Rv2034,	Rv2035,	 HigA,	 Rv1989,	 Rv1990	 and	 Rv0837	 proteins	 belonging	 to	 toxin-antitoxin	systems	 were	 also	 identified	 in	 the	 dormant	 bacteria,	 indicating	 their	 role	 in	adaptation	 during	 stress	 condition.	 	 The	 role	 of	 Rv2034	 has	 been	 studied	 in	persistence,	 but	 the	 function	 of	 other	 proteins	 can	 be	 analyzed	 to	 provide	 new	testable	hypotheses	about	the	role	of	these	proteins	in	dormancy.		Thus,	the	flows	or	paths	perturbed	during	dormancy	were	identified	in	this	study.		To	 get	 a	 better	 understanding	 of	 the	 metabolic	 network	 active	 in	 mycobacteria	under	 different	 conditions,	 experiments	 were	 performed	 in	 Mycobacterium	
smegmatis	 MC2	 155.	 The	 non-pathogenic	 strain	 of	 genus	 Mycobacteria,	
Mycobacterium	 smegmatis,	 is	 used	 as	 a	 surrogate	 to	 carry	 out	 molecular	 biology	studies	 of	 Mtb.	Mycobacterium	smegmatis	 MC2	 155	 (Msm)	 is	 the	 commonly	 used	laboratory	strain	for	experimental	purpose.	In	order	to	obtain	a	clear	understanding	of	how	comparable	are	the	metabolic	networks	between	the	virulent	M.	tuberculosis	H37Rv	and	the	model	system	Msm,	the	 latter	model	 is	 first	studied	systematically.		In	Chapter	6,	first	the	functional	annotation	of	the	Msm	genome	was	carried	out	and	the	 genes	 were	 categorized	 into	 different	 Tuberculist	 classes	 based	 on	 homology	with	the	Mtb	genome.	A	high-throughput	growth	characterization	was	carried	out	to	characterize	the	strain	systematically	in	terms	of	different	carbon,	nitrogen	or	other	sources	that	promoted	growth	and	thus	served	as	nutrients	and	those	that	did	not,	together	 yielding	 a	 genome-phenome	 correlation	 in	 Msm.	 Gene	 expression	 was	measured	 and	 used	 for	 explaining	 the	 observed	 phenotypic	 behavior	 of	 the	organism.	 Together	 with	 the	 genome	 sequence,	 the	 transcriptome	 and	 phenome	analysis,	 a	 set	 of	 about	 257	 different	 metabolic	 pathways	 were	 identified	 to	 be	feasible	in	wild-type	Msm.		About	284	different	carbon,	nitrogen	source	and	nutrient	supplements	were	tested	in	this	experiment	and	167	of	them	supported	growth	of	Msm.	 This	 indicates	 that	 the	 compounds	 enter	 the	 cells	 and	 are	 metabolized	efficiently,	 thus	yielding	 similar	phenotypes.	The	expressed	genes	and	metabolites	supporting	growth	were	mapped	to	the	metabolic	network	of	Msm,	thus	helping	in	the	identification	of	feasible	metabolic	routes	in	Msm.	A	comparative	study	between	Msm	and	Mtb	revealed	that	these	organisms	share	similarity	in	the	nutrient	sources	
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that	are	utilized	 for	growth.	The	study	provides	experimental	proof	 to	 identify	 the	feasible	 metabolic	 routes	 in	 Msm,	 and	 this	 can	 be	 used	 for	 understanding	 the	metabolic	 capability	 in	 the	 two	 organisms	 under	 different	 conditions	 providing	 a	basis	to	understand	adaptations	during	dormancy.		In	 the	 last	 part	 of	 the	 work	 presented	 in	 this	 thesis,	 the	 metabolic	 shift	 in	 the	pathogen	was	 studied	 using	 a	 genome-scale	metabolic	model	 of	Mtb	 (Chapter	 7).	The	model	contains	information	of	the	reactions,	metabolites	and	genes	involved	in	the	reactions.	Flux	balance	analysis	(FBA)	was	carried	out	by	integrating	normalized	gene	 expression	 data	 (Wayne	 model	 and	 multiple-stress	 model	 transcriptome	considered	in	Chapter	5)	to	identify	the	set	of	reactions,	which	have	a	higher	flux	in	the	dormant	condition	as	compared	to	the	control	replicating	condition.	Glutamate	metabolism	 along	 with	 propionyl	 CoA	 metabolism	 emerge	 as	 major	 up-regulated	processes	 in	dormant	Mtb.	Next,	with	an	objective	of	 identifying	essential	genes	 in	dormant	Mtb,	 a	 systematic	 in	silico	single	gene	knock-out	 analysis	was	 carried	out	where	each	gene	and	it's	associated	reaction	was	knocked	out	of	the	model,	one	at	a	time	and	the	ability	of	the	model	to	reach	its	objective	function	assessed.	About	168	common	 genes	 in	 Wayne	 model	 and	 multiple-stress	 model	 were	 identified	 as	important	 in	Mtb	after	 the	knockout	analysis.	 	Essentiality	 is	 in	essence	a	 systems	property	and	requires	to	be	probed	through	multiple	angles.	Towards	this,	essential	genes	 were	 identified	 in	 Mtb	 using	 a	 multi-level	 multi-scale	 systems	 biology	approach.	 About	 283	 genes	were	 identified	 as	 essential	 on	 the	 basis	 of	 combined	analysis	of	transcriptome	data,	FBA,	network	analysis	and	phyletic	retention	studies	in	Mtb.	168	genes	identified	as	important	in	dormant	Mtb	were	compared	with	283	essential	genes	and	about	91	genes	were	 found	 to	be	essential.	Finally,	among	 the	set	 of	 essential	 genes,	 those	 that	 satisfy	 other	 criteria	 for	 a	 drug	 target	 were	analyzed	 using	 the	 list	 of	 high-confidence	 drug	 targets	 of	 Mtb	 available	 in	 the	laboratory	along	with	their	associated	drug	or	drug-like	molecules.	38	out	of	the	168	important	genes	in	Mtb	were	found	to	have	one	or	more	drugs	associated	with	them	from	 the	 DrugBank	 database.	 	 Colchicin-Rv1655,	 Raloxifene-Rv1653,	 Bexarotene-Rv3804,	 Rosiglitazone-Rv3804	 are	 top-scoring	 drug-target	 pairs	 that	 can	 be	explored	 for	 killing	 dormant	 bacilli.	 The	 study	 has	 thus	 been	 useful	 in	 identifying	important	proteins,	reactions	and	drug	targets	in	dormant	Mtb.	
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		In	 summary,	 the	 thesis	 presents	 a	 comprehensive	 systems-level	 understanding	 of	various	 aspects	 of	 host	 responses	 and	 pathogen	 adaptation	 during	 latent	 TB	infection.	Key	host	and	pathogen	factors	involved	in	LTBI	are	identified	that	serve	as	useful	pointers	for	deriving	strategies	for	tackling	a	latent	infection.																							
Notation	and	Abbreviations		 ATP	 Adenosine	triphosphate	
